Swiss
drugmaker Roche has denied that there have been cuts in the supply of
some drugs, mainly anti-tumor over unpaid hospital and recalls that,
pursuant to the obligations of the company, has decided to modify the
terms of trade with some hospitals.
In
response to a report published by El Pais in advancing that some
hospitals are suffering shortages could, company sources have pointed to
Europa Press that "business conditions have changed with several
Spanish hospitals to prevent further debt grow and continue to ensure normality in access to medicines ".
Therefore,
"it does not mean a power" warning, but there has been a hardened
conditions at three hospitals in the Valencia region, two hospitals of
Castilla-La Mancha, Castilla Y Leon three and three of Andalusia.
So,
to all schools, except that of Castellón, which has been applied to the
cash payment, they have set the credit limit, "thereby been given a
single claim" with which Roche aims to establish a ceiling on the debt in those regions, in particular in those centers.
This
decision comes after months of negotiations with the ministries of the
different regions and these negotiations has been done in "parallel",
taking into account the hospitals involved. "The
debt problem is that in certain cases submitted payment delays very
important," say sources in the laboratory indicate that "each case is
different."
The
company, which says it is "seeking solutions to these problems,"
Certainly in the next week might be affected some other hospital, and
they hope soon to become effective "Plan Payment to Providers' launched
by the Government. They also clarify that the provision to other public and private hospitals as well as pharmacies, is taking quite normally.
In
fact, from Roche positively highlighted this mechanism offers a
solution to the territorial governments to do against these payments.
The total debt is currently around Roche 500 million euros and, remember, 80 percent of sales are to hospitals. "Roche
unlike other laboratories focuses on the supply to hospitals, in that
sense we are more vulnerable to default to hospitals," explained the
sources.
"We
need these funds for our research activities and supplies, and continue
to meet its obligations to third parties. The pharmacist has to
charge", added from the company.PAYMENT WILL CONTROL HEALTH
The
Minister of Health, Social Services and Equal, Ana Mato, stated on
Monday that his department will "control" the payment of pharmaceutical
communities to not produce "any kind of shortage" of drugs, after that a company has advanced will stop supplying drugs to some hospitals.
This
was recognized by the health minister at a breakfast briefing Forum
Spain Innova with the cardiologist Valentin Fuster, in response to the
possible shortage of Swiss drugmaker Roche in some hospitals.
In
this situation, Mato recalled that when the Government had reached a
"late payments to the major pharmaceutical" the central government has
already corrected and, in fact, stated that "we are paying the debts
that had with these companies. "
"In
the coming days are going to receive that payment, and will ever trust
this country that when they see that things have begun to change," he
stressed Mato, also noting that communities should be "aware that medications are paramount."
source: www.europapress.es
